The covid booster shots have been making headlines all over the place these days, and the discussion about who should get them intensifies with each passing day.
Now, it’s been just revealed that U.S. Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said that the Pfizer coronavirus vaccine booster shot is suitable for younger at-risk workers.
Fox News also made sure to report that this is seen as a rare break from the agency’s Advisory Committee on Immunization Practices panel.
Booster shots discussion continues
The same article posted by Fox News reveals that the panel had recommended the booster for Americans 65 and older and for those over 50 with underlying medical conditions. As you probably know by now, they voted against the younger at-risk worker recommendation.
Walensky put it back in and made sure to highlight the fact that it aligns with a U.S. Food and Drug Administration booster authorization from earlier this week.
“As CDC Director, it is my job to recognize where our actions can have the greatest impact.”
This is what Walensky said in a statement. He continued and said:
“At CDC, we are tasked with analyzing complex, often imperfect data to make concrete recommendations that optimize health. In a pandemic, even with uncertainty, we must take actions that we anticipate will do the greatest good.”
New viable covid treatment pops up
It’s been just reported that there’s a covid therapy that is derived from a llama named Fifi which has shown significant potential in early trials.
This is a treatment made of nanobodies which are smaller and simpler versions of antibodies – llamas and camels produce this naturally as a response to the infection.
This therapy has been tested in humans, and experts are saying that it could be given as a simple nasal spray to treat and prevent early infection.
Prof James Naismith described nanobodies as “fantastically exciting”.